News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-04-05-2017
Volume12
Issue 4

Butterworth Laboratories Expands UK Lab Operations

The company has secured an additional facility in Hampton, Middlesex, as part of a project to expand its UK-based operations by 15% in 2017.

Butterworth Laboratories, a provider of analytical services, announced on March 27, 2017 that it has secured an additional facility in Hampton, Middlesex, as part of a project to expand its laboratory operations by 15% in the United Kingdom in 2017. This expansion is the first phase of a longer term plan to deliver increased capacity of 60% by 2020. Butterworth Labs is expecting strong growth and says that the move will secure the Teddington facility as the UK laboratory operations, while providing the platform for continued growth in key areas.

The expansion coincides with the appointment of David Hawkins as managing director. Hawkins was formerly the company's chief operating officer. Doris Butterworth continues on the board as chairman along with finance director John Gearey and newly appointed non-executive director Patrick Stewart.

Source: Butterworth Laboratories

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content